期刊文献+

肿瘤坏死因子-α在溃疡性结肠炎中的表达及其作用探讨 被引量:12

Expression and Effect of Tumor Necrosis Factor-α in Ulcerative Colitis
下载PDF
导出
摘要 背景:随着肿瘤坏死因子(TNF)-α单克隆抗体治疗克罗恩病(CD)获得成功,TNF-α在CD发病机制中的作用已得到肯定,但其在溃疡性结肠炎(UC)中的作用尚需进一步研究。目的:探讨TNF-α在UC中的表达及其与疾病活动性和组织学分级的关系,研究TNF-α在UC中的作用。方法:35例UC患者和15例对照者经结肠镜取活检,标本分别用于组织学诊断、分级和原位杂交检测结肠黏膜TNF-αmRNA的表达。根据Powell-Tuck评分系统对UC患者作疾病活动性评分。结果:UC黏膜TNF-αmRNA阳性细胞百分率较对照组显著增高(P<0.01),但其表达与疾病活动性和组织学分级无相关性(P>0.05)。表达TNF-αmRNA的炎性细胞多分布于远离上皮层的固有层下部。结论:UC黏膜TNF-αmRNA的表达确有增高,但与疾病活动性和组织学分级均无明确关系。TNF-α在UC发生、发展过程中的作用尚不肯定。 Background: With the success of anti-tumor necrosis factor (TNF)-α monoclonal antibody used in the management of Crohn's disease (CD), the effect of TNF-α in the pathogenesis of CD had been confirmed, but its role in ulcerative colitis (UC) needs further investigation. Aims: To investigate the expression and effect of TNF-α in UC, as well as its relationship with the activity and histological grade of UC. Methods: Fifty biopsy specimens were obtained endoscopically from 35 patients with UC and 15 controls, respectively. The specimens were used for diagnosis and histological grading, as well as in situ hybridization for TNF-α mRNA in colonic mucosa. The disease activity index of UC was graded according to PowellTuck scoring system. Results: The percentage of immunopositive cells for TNF-α mRNA in UC mucosa was increased considerably as compared with that in the controls (P〈0.01), but there was no correlations between TNF-α mRNA expression and the disease activity or histological grade of UC (P〉0.05). In UC mucosa, TNF-α mRNA-positive inflammatory cells were mainly localized at the basal area of lamina propria, which were far away from the epithelial lining. Conclusions: The expression of TNF-α mRNA in UC mucosa increases considerably, but no exact relationship is found between its expression and the disease activity or histological grade. The effect of TNF-α in the development of UC remains uncertain.
出处 《胃肠病学》 2005年第5期269-272,共4页 Chinese Journal of Gastroenterology
基金 四川省科技厅重点科技项目(No.02sy029-112)资助
  • 相关文献

参考文献12

  • 1Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF,Ramos R, Britton H, Moran T, Karaliuskas R, Duerr RH,Achkar JP, Brant SR, Bayless TM, Kirschner BS,Hanauer SB, Nunez G, Cho JH. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease.Nature, 2001, 411: 603~606.
  • 2Lesage S, Zouali H, Cezard JP, Colombel JF, Belaiche J,Almer S, Tysk C, O'Morain C, Gassull M, Binder V,Finkel Y, Modigliani R, Gower-Rousseau C, Macry J,Merlin F, Chamaill1ard M, Jannot AS, Thomas G, Hugot JP; EPWG-IBD Group; EPIMAD Group; GETAID Group.CARD15/NOD2 mutational analysis and genotypephenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet, 2002, 70: 845~857.
  • 3Noguchi M, Hiwatashi N, Liu Z, Toyota T. Secretion imbalance between tumour necrosis factor and its inhibitor in inflammatory bowel disease. Gut, 1998, 43: 203~209.
  • 4Akobeng AK, Zachos M. Tumor necrosis factor-alpha antibody for induction of remission in Crohn's disease.Cochrane Database Syst Rev, 2004, 1: CD003574.
  • 5Rutgeerts P, Van Assche G, Vermeire S. Optimizing antiTNF treatment in inflammatory bowel disease. Gastroenterology, 2004, 126: 1593~1610.
  • 6欧阳钦,潘国宗,温忠慧,万学红,胡仁伟,林三仁,胡品津.对炎症性肠病诊断治疗规范的建议[J].中华消化杂志,2001,21(4):236-239. 被引量:1123
  • 7Powell-Tuck J, Bown RL, Lennard-Jones JE. A comparison of oral prednisolone given as single or multiple daily doses for active proctocolitis. Scand J Gastroenterol, 1978, 13: 833~837.
  • 8Truelove SC, Witts LJ. Cortisone in ulcerative colitis;final report on a therapeutic trial. Br Med J, 1955, 4947:1041~1048.
  • 9Ruemmele FM, Seidman EG. Cytokine-intestinal epithelial cell interactions: implications for immune mediated bowel disorders. Acta Paediatr Sin, 1998, 39: 1~8.
  • 10Van Deventer SJ. Tumour necrosis factor and Crohn's disease. Gut, 1997, 40: 443~448.

共引文献1122

同被引文献130

引证文献12

二级引证文献68

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部